Faculty

Amanda Phipps

Associate Professor, Epidemiology
Associate Chair, Epidemiology

206-667-7741
aphipps@fhcrc.org

Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of California (Berkeley), 2003
BA Biological Sciences, Northwestern University, 2001

Contact

206-667-7741
aphipps@fhcrc.org

University of Washington
Office F-250A
Box 357236
Department of Epidemiology, School of Public Health
Seattle, WA 98195
Fred Hutchinson Cancer Research Center
Box 358080
1100 Fairview Avenue North, M4-C308
Seattle, WA 98109

Research Interests

Dr. Phipps's research interests span the fields of cancer epidemiology, molecular epidemiology, and clinical epidemiology. Her current projects focus on the relationship between modifiable lifestyle factors (e.g., smoking, obesity) and survival in individuals with biologically-distinct subtypes of colorectal cancer, and the impact of sleep and sleep disorders on cancer incidence and survival. She also has an interest in molecular subtypes of breast cancer, particularly in risk factors for the poor-prognosis triple-negative subtype of breast cancer.

Recent Publications (PubMed)

Body Mass Index and Molecular Subtypes of Colorectal Cancer.
(2022 Nov 29)
J Natl Cancer Inst
Murphy N, Newton CC, Song M, Papadimitriou N, Hoffmeister M, Phipps AI, Harrison TA, Newcomb PA, Aglago EK, Berndt SI, Brenner H, Buchanan DD, Cao Y, Chan AT, Chen X, Cheng I, Chang-Claude J, Dimou N, Drew D, Farris AB, French AJ, Gallinger S, Georgeson P, Giannakis M, Giles GG, Gruber SB, Harlid S, Hsu L, Huang WY, Jenkins MA, Laskar RS, Le Marchand L, Limburg P, Lin Y, Mandic M, Nowak JA, Obón-Santacana M, Ogino S, Qu C, Sakoda LC, Schoen RE, Southey MC, Stadler ZK, Steinfelder RS, Sun W, Thibodeau SN, Toland AE, Trinh QM, Tsilidis KK, Ugai T, Van Guelpen B, Wang X, Woods MO, Zaidi SH, Gunter MJ, Peters U, Campbell PT

T cell-inflamed gene expression profile is associated with favorable disease-specific survival in non-hypermutated microsatellite-stable colorectal cancer patients.
(2022 Nov 7)
Cancer Med
Yin H, Harrison TA, Thomas SS, Sather CL, Koehne AL, Malen RC, Reedy AM, Wurscher MA, Hsu L, Phipps AI, Zaidi SHE, Newcomb PA, Peters U, Huyghe JR

Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old.
(2022 Sep 13)
Cancer Epidemiol Biomarkers Prev
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Corley DA, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J

Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival.
(2022 Dec)
Gastroenterology 163(6): 1531-1546.e8
Pai RK, Banerjee I, Shivji S, Jain S, Hartman D, Buchanan DD, Jenkins MA, Schaeffer DF, Rosty C, Como J, Phipps AI, Newcomb PA, Burnett-Hartman AN, Le Marchand L, Samadder NJ, Patel B, Swallow C, Lindor NM, Gallinger SJ, Grant RC, Westerling-Bui T, Conner J, Cyr DP, Kirsch R, Pai RK

Association between germline variants and somatic mutations in colorectal cancer.
(2022 Jun 17)
Sci Rep 12(1): 10207
Barfield R, Qu C, Steinfelder RS, Zeng C, Harrison TA, Brezina S, Buchanan DD, Campbell PT, Casey G, Gallinger S, Giannakis M, Gruber SB, Gsur A, Hsu L, Huyghe JR, Moreno V, Newcomb PA, Ogino S, Phipps AI, Slattery ML, Thibodeau SN, Trinh QM, Toland AE, Hudson TJ, Sun W, Zaidi SH, Peters U

Show complete publication list